Detalhe da pesquisa
1.
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.
Int J Mol Sci
; 24(16)2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37629147
2.
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors.
PLoS Pathog
; 14(8): e1007209, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30080893
3.
Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer.
J Cell Physiol
; 234(2): 1768-1779, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132876
4.
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis.
BMC Cancer
; 19(1): 126, 2019 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30732578
5.
Cancer immunoprevention: from mice to early clinical trials.
BMC Immunol
; 19(1): 16, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29902992
6.
Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment.
Hum Mol Genet
; 23(6): 1453-66, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24163135
7.
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis.
Breast Cancer Res
; 17: 70, 2015 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25997501
8.
Preclinical therapy of disseminated HER-2⺠ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.
PLoS Pathog
; 9(1): e1003155, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23382683
9.
Vaccines for tumour prevention.
Nat Rev Cancer
; 6(3): 204-16, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16498443
10.
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.
BMC Genomics
; 15 Suppl 3: S1, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25077564
11.
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.
Breast Cancer Res
; 16(1): R10, 2014 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24451168
12.
Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells.
J Transl Med
; 12: 122, 2014 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24886178
13.
Rethinking herpes simplex virus: the way to oncolytic agents.
Rev Med Virol
; 21(4): 213-26, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21626603
14.
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells.
Proc Natl Acad Sci U S A
; 106(22): 9039-44, 2009 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19458262
15.
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC.
Transl Lung Cancer Res
; 11(11): 2216-2229, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519016
16.
2011: the immune hallmarks of cancer.
Cancer Immunol Immunother
; 60(3): 319-26, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21267721
17.
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy.
Cells
; 10(7)2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359977
18.
IFN-γ and CD38 in Hyperprogressive Cancer Development.
Cancers (Basel)
; 13(2)2021 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33467713
19.
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression.
Oncogenesis
; 10(11): 77, 2021 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775465
20.
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft.
Sci Rep
; 11(1): 1563, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452364